| DAY 1 - 22 MARCH 2011 - Sheikh Rashid Hall A |
| SESSION 1 - Reinventing Pharmacy Practice | Chairperson: PROF. ABDULLA MOLOKHIA |
| 11:00 β 11:45 |
Dr. Kathryn R Schultz, Pharm.D., FASHP
Director of Pharmacy - Bethesda Hospital, St Paul, USA |
The ASHP Pharmacy Practice Model Initiative |
| 11:45 β 12:30 |
Prof. Abdel Aziz Saleh, Ph.D.
Former Deputy Regional Manager WHO/EMRO |
Improving medicine use: System approach |
| 12:30 β 13:15 |
Prof. Jeff Poston, PhD, MRPharmS.
Executive Director - Canadian Pharmacists Association, Ottawa, Canada |
New roles for pharmacists β barriers and opportunities |
| 13:15 β 14:30 |
LUNCH BREAK |
|
| |
| DAY 1 - 22 MARCH 2011 - Sheikh Rashid Hall B |
| SESSION 1 - Science, Research & Marketing | Chairperson: DR. MAHMOUD M. MARASHI |
| 11:00 β 11:45 |
Prof. Randy P. Juhl, Ph.D.
Vice Chancellor for Research Conduct and Compliance, Distinguished Service Professor of Pharmacy, University of Pittsburgh, USA |
Science vs. Marketing:Β The State of Relationships Between Healthcare Practitioners and Pharmaceutical Manufacturers in the United States |
| 11:45 β 12:30 |
Dr. Ibrahim Al Khars (Ph.D.)
College of Pharmacy, University of Florida, Florida, USA |
Drug truth and the myth about Pharma R & D |
| 12:30 β 13:15 |
Prof H.G.M. Leufkens, Ph.D.
Utrecht University, Faculty of Science
Utrecht Institute for Pharmaceutical Sciences (UIPS)
Division of Pharmacoepidemiology and Pharmacotherapy
Utrecht, The Netherlands |
Globalization of clinical trials, scientific, regulatory and ethical challenges |
| 13:15 β 14:30 |
LUNCH BREAK |
| SESSION 2 - Oncology Pharmacy | Chairperson: PROF. ISMAIL HEWALA |
| 14:30 β 15:15 |
MSc.Ph. Ahmet Sami Bosnak,
Gaziantep University of Medical Faculty.
Gaziantep Oncology Hospital, Gaziantep, Turkey |
Importance of oncology pharmacy in chemotherapy treatments, are residual drugs loss or gain? |
|
| |
|
